Skip to main content
Back

Asian Credits

Asian credits posted an impressive 20191  thanks to a favourable investment backdrop: low yields drove capital flows into the region, issuance was robust, and corporate fundamentals remained solid2. As we enter 2020, we do not expect a significant deterioration of credit profiles, but weaker privately-owned enterprises and less strategically-important state-owned companies may face increased pressure. In this outlook, Fiona Cheung, Head of Credit, Asia, outlines why investors should remain vigilant and selective in 2020.

Accommodative easing and strong investor demand drove 2019 performance

Asian credit markets moved higher in 2019, as credit spreads narrowed on the back of numerous positive macro factors.

  • “Lower for longer” global interest rate landscape: The Federal Reserve (Fed)’s progressively dovish tone throughout 2019, coupled with the European Central Bank’s re-entry into quantitative easing, led to a sharp repricing in bond markets. US Treasuries exhibited significant volatility, with 10-year yields ending the year sharply lower3;
  • Increased capital inflows: Lower (and even negative) yields for some developed countries’ bonds4 prompted global investors to seek higher returns in emerging markets. Asia was a key beneficiary of increased capital inflows, particularly as credit issuance remained supportive;
  • Stronger monetary accommodation: Numerous Asian central banks aggressively lowered rates due to declining global yields, receding inflationary pressures and slowing global growth.  India, Indonesia, and the Philippines were the most active markets, with the latter two cutting rates and lowering the bank reserve requirement ratio to boost lending levels.

Asian Credits: Strong fundamentals and increased market differentiation will define 2020

In 2020, we believe that economic growth in developed countries will remain subdued, but Asian economic growth should remain relatively strong with muted inflationary pressures5. We also think that despite notable monetary loosening last year, some Asian markets, such as Indonesia and India, have additional room for accommodation to boost economic growth. Regional markets may also benefit from shifting supply chains away from China towards other manufacturing bases. Overall, this growth differentiation should continue to support regional credits if Sino-US trade tensions do not materially worsen, which is our base-case scenario.

From a supply perspective, we envisage a marginal increase in issuance with modest redemptions, which will be supportive for the market6. The trend of Asia-based institutional demand for regional credit (especially in the high-yield space)7 should continue to deepen in 2020, providing a stable “home base” that is supportive of prices during cases of amplified market volatility. We forecast that the region’s default rate, as a lagging indicator of credit quality, will gradually tick upward as a delayed reflection of slowing global growth8.  As a result, we believe that security selection and bottom-up research will remain vital, particularly as idiosyncratic risks increase.

Based on these factors, our view is that Asian credit markets are poised for further gains in 2020, with greater differentiation. In Indonesia, we are constructive on high-quality credits in key sectors such as property and coal mining.  While in India, we see attractive yield and steady credit standings in areas such as steel and renewables. 

China Credits: Opportunities amid amplified risks

The Chinese economy may face ongoing headwinds from trade tensions in 2020, but we still expect it to grow by 5.5%-6%. The Chinese government should continue to provide support through targeted fiscal measures and accommodative monetary policy, but we don’t expect full-fledged credit expansion similar to 2008-2009 due to ample market liquidity and building inflationary pressures. With economic challenges and capital outflow pressure, the RMB should remain weaker, above the threshold of 7 RMB to 1 US dollar in 2020.

Looking at the market’s overall fundamentals, we do not see a significant deterioration in credit, although more modest performance is likely. We prefer the credits of strategically important state-owned enterprises (SOEs) and Local Government Financing Vehicles (LGFVs), which stand to benefit from continued government support via lending and fiscal stimulus. Examples include toll-road operators, railway operators or companies involved in strategic projects at the national level.

We are also constructive on the property sector, which accounts for significant issuance in the high-yield market and a high proportion of GDP, as well as the banking sector. Reported banks’ problem loans are improving and the capital-adequacy ratio remains healthy9, we do not anticipate a substantial deterioration in bank credits. We are less positive on more economically cyclical industries, such as industrials, which have a significant amount of debt set to mature in 2020. Having said that, we are also on the lookout for potential high-quality names in this category that may have been oversold in 2019.

Finally, defaults in China’s credit markets remain a hot topic among investors. While defaults in China have largely been concentrated in the private sector, we did see a notable change in the attitude of the Chinese government towards handling financial distress of SOEs, particularly in the banking and LGFV sectors10.  We believe that the Chinese government will increasingly allow systemically unimportant commercial sectors to fail as a means to increase discipline and reduce moral hazard among onshore credit investors.

Environment, Social & Governance (ESG) factors will continue to rise in importance

Although the topic of ESG is not new one, its importance is gaining ground in Asia. Our credit team has taken numerous steps to build our ESG capabilities, having recently become a signatory to the UN Principles for Responsible Investment (PRI).

We have now formally incorporated a robust ESG perspective into our investment analysis and decision-making processes. Apart from the traditional research and financial analysis on every issuer, our credit analysts work closely with our dedicated ESG research team to review ESG factors. In addition, a dedicated ESG taskforce for our Asian Fixed Income portfolios has been established to track the progress of our ESG integration. As we have strong local footprints in Asia, with a team of over 20 credit analysts, this differentiates us from other competitors who are traditionally focused on Europe.

Finally, our unique on-the ground presence in over 10 Asian markets gives a competitive advantage in understanding the three discrete elements of ESG.  Often, the true risks of ESG can only be seen through robust on-the ground research coupled with a quantifiable measurement process. This approach allows us to “notch” ratings up and down based on a long-term view of risk.

Besides our corporate framework, we are ready to launch a new structure for sovereign credits in early 2020. This should give us a superior advantage when measuring Asian corporates and sovereigns, particularly on the “Governance” issue. We expect the “G” factor to become increasingly prominent when evaluating Asia’s corporates due to concentrated ownership.

Fiona Cheung, Head of Credit, Asia
  1. JACI Investment grade rose by 10.85%, with spreads narrowing by 28.6 bps. JACI HY rose by 11.61% with spreads narrowing by 38.9 bps. Data as of 5 December 2019.
  2. YTD new issuance amounted to US$265 billion, second highest since 2007. JP Morgan, as of November 2019.
  3. The 10-year US Treasury yield was at 1.77% as of 11/29/2019- while it was 2.69% as of 12/31/2018.
  4. The total of negative interest rate bonds was roughly US $11.5 trillion or 20% of all bond issuance.  Financial Times, as of 19 November 2019.
  5. International Monetary Fund Global Outlook, as of October 2019.
  6. Issuance for 2019 was $265 billion in 2019 (YTD through 31 October 2019):  $152 billion were investment grade, while $109 billion were high-yield. JP Morgan, as of November 2019. Redemptions were around US$ 190 billion; there will be a similar level of redemptions due next year. Source: Barclays, as of October 2019.
  7. By investor type, insurance/pension represents an average 65% of allocation of high-yield new issues in 2019, versus 48% in 2018; November 2019, JP Morgan.
  8. According to Moody's, Asia’s trailing 12-month (TTM) non-financial high-yield corporate default rate was 1.8% at the end of July 2019, lower than the 2.9% at end-2018. Moody’s expects the TTM default rate to bottom out at 0.8% in January 2020 and gradually increase to hit 1.6% in June 2020.
  9. Manulife Investment Management, November 2019.
  10. Both Baoshang Bank and Bank of Jinzhou were effectively allowed to fail without government bailouts. In November, the defacto default of Tewoo Group represented the first onshore defacto default in 20 years. Peking University Founder Group, a company perceived to benefit from strong government support, failed to repay onshore creditors in December.

Disclaimers

Investing involves risks, including the potential loss of principal. Financial markets are volatile and can fluctuate significantly in response to company, industry, political, regulatory, market, or economic developments. These risks are magnified for investments made in emerging markets. Currency risk is the risk that fluctuations in exchange rates may adversely affect the value of a portfolio’s investments.

The information provided does not take into account the suitability, investment objectives, financial situation, or particular needs of any specific person. You should consider the suitability of any type of investment for your circumstances and, if necessary, seek professional advice.

This material, intended for the exclusive use by the recipients who are allowable to receive this document under the applicable laws and regulations of the relevant jurisdictions, was produced by, and the opinions expressed are those of, Manulife Investment Management as of the date of this publication, and are subject to change based on market and other conditions. The information and/or analysis contained in this material have been compiled or arrived at from sources believed to be reliable, but Manulife Investment Management does not make any representation as to their accuracy, correctness, usefulness, or completeness and does not accept liability for any loss arising from the use of the information and/or analysis contained. The information in this material may contain projections or other forward-looking statements regarding future events, targets, management discipline, or other expectations, and is only as current as of the date indicated. The information in this document, including statements concerning financial market trends, are based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Manulife Investment Management disclaims any responsibility to update such information.

Neither Manulife Investment Management or its affiliates, nor any of their directors, officers or employees shall assume any liability or responsibility for any direct or indirect loss or damage or any other consequence of any person acting or not acting in reliance on the information contained herein. All overviews and commentary are intended to be general in nature and for current interest. While helpful, these overviews are no substitute for professional tax, investment or legal advice. Clients should seek professional advice for their particular situation. Neither Manulife, Manulife Investment Management, nor any of their affiliates or representatives is providing tax, investment or legal advice. Past performance does not guarantee future results. This material was prepared solely for informational purposes, does not constitute a recommendation, professional advice, an offer or an invitation by or on behalf of Manulife Investment Management to any person to buy or sell any security or adopt any investment strategy, and is no indication of trading intent in any fund or account managed by Manulife Investment Management. No investment strategy or risk management technique can guarantee returns or eliminate risk in any market environment. Diversification or asset allocation does not guarantee a profit nor protect against loss in any market. Unless otherwise specified, all data is sourced from Manulife Investment Management.

Manulife Investment Management

Manulife Investment Management is the global wealth and asset management segment of Manulife Financial Corporation. We draw on more than 150 years of financial stewardship to partner with clients across our institutional, retail, and retirement businesses globally. Our specialist approach to money management includes the highly differentiated strategies of our fixed-income, specialized equity, multi-asset solutions, and private markets teams—along with access to specialized, unaffiliated asset managers from around the world through our multimanager model.

These materials have not been reviewed by, are not registered with any securities or other regulatory authority, and may, where appropriate, be distributed by the following Manulife entities in their respective jurisdictions. Additional information about Manulife Investment Management may be found at www.manulifeam.com.

Australia: Hancock Natural Resource Group Australasia Pty Limited, Manulife Investment Management (Hong Kong) Limited. Brazil: Hancock Asset Management Brasil Ltda. Canada: Manulife Investment Management Limited, Manulife Investment Management Distributors Inc., Manulife Investment Management (North America) Limited, Manulife Investment Management Private Markets (Canada) Corp. China: Manulife Overseas Investment Fund Management (Shanghai) Limited Company. European Economic Area and United Kingdom: Manulife Investment Management (Europe) Ltd. which is authorised and regulated by the Financial Conduct Authority, Manulife Investment Management (Ireland) Ltd. which is authorised and regulated by the Central Bank of Ireland. Hong Kong: Manulife Investment Management (Hong Kong) Limited. Indonesia: PT Manulife Aset Manajemen Indonesia. Japan: Manulife Asset Management (Japan) Limited. Malaysia: Manulife Investment Management (M) Berhad (formerly known as Manulife Asset Management Services Berhad) 200801033087 (834424-U). Philippines: Manulife Asset Management and Trust Corporation. Singapore: Manulife Investment Management (Singapore) Pte. Ltd. (Company Registration No. 200709952G). Switzerland: Manulife IM (Switzerland) LLC. Taiwan: Manulife Investment Management (Taiwan) Co. Ltd. Thailand: Manulife Asset Management (Thailand) Company Limited. United States: John Hancock Investment Management LLC, Manulife Investment Management (US) LLC, Hancock Capital Investment Management, LLC and Hancock Natural Resource Group, Inc. Vietnam: Manulife Investment Fund Management (Vietnam) Company Limited. 

Manulife Investment Management, the Stylized M Design, and Manulife Investment Management & Stylized M Design are trademarks of The Manufacturers Life Insurance Company and are used by it, and by its affiliates under license. 

505329

The VHIS Office recently discovered a translation error in the Chinese version of the Schedule of Surgical Procedures of the Certified Plan Policy Template. In the fracture/dislocation section of the Surgical Schedule, “clavicle” on the 8th and 12th items was mistranslated as “scapula” and “scapula” on the 13th item was mistranslated as “clavicle”. Manulife has reviewed and revised the relevant product information of Manulife’s VHIS certified plans upon the VHIS Office’s request, and has revised the Chinese version of the certified plans’ policy provisions accordingly. The English version of the policy provisions is not affected. For any enquiries, please contact Manulife’s service hotline at 2108 1188.

View more

The VHIS Office recently discovered a translation error in the Chinese version of the Schedule of Surgical Procedures of the Certified Plan Policy Template. In the fracture/dislocation section of the Surgical Schedule, “clavicle” on the 8th and 12th items was mistranslated as “scapula” and “scapula” on the 13th item was mistranslated as “clavicle”. Manulife has reviewed and revised the relevant product information of Manulife’s VHIS certified plans upon the VHIS Office’s request, and has revised the Chinese version of the certified plans’ policy provisions accordingly. The English version of the policy provisions is not affected. For any enquiries, please contact Manulife’s service hotline at 2108 1188.

View more
Confirm